Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells

被引:16
|
作者
Uemura, Y [1 ]
Kobayashi, M [1 ]
Nakata, H [1 ]
Harada, R [1 ]
Kubota, T [1 ]
Taguchi, H [1 ]
机构
[1] Kochi Med Sch, Dept Internal Med, Nanko Ku, Kochi 7838505, Japan
关键词
serum deprivation; G-CSF; GM-CSF; OKa-C-1; MI-4;
D O I
10.1002/ijc.20023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We previously established 2 lung cancer cell lines, OKa-C-I and MI-4, which constitutively produce an abundant dose of granulocyte-colony stimulating factor (G-CSF) and granulocyte macrophage-colony stimulating factor (GM-CSF). Many other cases with G-CSF or GM-CSF producing tumors have been reported up to the present. However, the biological properties of the overproduction of G-CSF and GM-CSF by tumor cells have not been well known. Several reports demonstrated the presence of an autocrine growth loop for G- CSF and GM-CSF in nonhematopoietic tumor cells. We showed that exogenous G-CSF and GM-CSF stimulated cell growth in a dose-dependent manner in OKa-C-I and MI-4 cells. We could detect the presence of G-CSF and GM-CSF receptors in both cell lines by RT-PCR analysis. We have previously shown that inflammatory cytokines, tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta enhance the expression of G-CSF and GM-CSF in the cell lines. However, the factors that regulate constitutive production of G-CSF or GM-CSF by tumor cells are still unknown well. In our study, we first reported that serum deprivation stimulated constitutive production of G-CSF and GM-CSF by lung tumor cells through activation of nuclear factor (NF)-kappaB and p44/42 mitogen-activated protein kinase (MAPK) pathway signaling. We suggest that G-CSF and GM-CSF constitutively produced by tumor cells could grow tumor itself and rescue tumor cells from the cytotoxicity of serum deprivation. (C) 2004 Wilely-Liss, Inc.
引用
收藏
页码:826 / 832
页数:7
相关论文
共 50 条
  • [1] Granulocyte macrophage-colony stimulating factor for treatment of chemotherapy extravasation
    Shamseddine, AI
    Khalil, AM
    Kibbi, AG
    Abu Nasr, TA
    Seoud, MAF
    El Saghir, NS
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (05) : 479 - 481
  • [2] Serum Granulocyte Macrophage-Colony Stimulating Factor: a Tumor Marker in Colorectal Carcinoma?
    Demirci, Umut
    Coskun, Ugur
    Sancak, Banu
    Ozturk, Banu
    Bahar, Burak
    Benekli, Mustafa
    Buyukberber, Suleyman
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (06) : 1021 - 1024
  • [3] Clinical applications of granulocyte-colony stimulating factor
    Sung, Lillian
    Dror, Yigal
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 1988 - 2002
  • [4] The Role of Granulocyte Macrophage-Colony Stimulating Factor in Gastrointestinal Immunity to Salmonellosis
    Coon, C.
    Beagley, K. W.
    Bao, S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2009, 70 (02) : 106 - 115
  • [5] Regulation of immunomodulatory functions by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in vivo
    Aman, MJ
    Stockdreher, K
    Thews, A
    Kienast, K
    Aulitzky, WE
    Farber, L
    Haus, U
    Koci, B
    Huber, C
    Peschel, C
    ANNALS OF HEMATOLOGY, 1996, 73 (05) : 231 - 238
  • [6] Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia
    Duru, F
    Ertem, U
    Tacyildiz, N
    Kirazli, S
    JOURNAL OF MEDICINE, 1995, 26 (5-6) : 241 - 252
  • [7] The effect of granulocyte macrophage-colony stimulating factor on glutathione and lipid peroxidation in a rat model
    Kilic, D
    Sayan, H
    Gönül, B
    Egehan, I
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (07): : 701 - 704
  • [8] Carcinosarcoma of the liver producing granulocyte-colony stimulating factor
    Aita, Kumi
    Seki, Kunihiko
    PATHOLOGY INTERNATIONAL, 2006, 56 (07) : 413 - 419
  • [9] Granulocyte-colony stimulating factor in the treatment of colchicine poisoning
    Critchley, JAJH
    Critchley, LAH
    Yeung, EA
    Young, RP
    Young, RJ
    Chan, TYK
    Goh, VKM
    HUMAN & EXPERIMENTAL TOXICOLOGY, 1997, 16 (04): : 229 - 232
  • [10] Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: Which to choose?
    Elfenbein, GJ
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 37 - 47